PF-03654746

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

2 competitors in Attention Deficit Hyperactivity Disorder

Drug Information

Target Indication

Attention Deficit Hyperactivity Disorder

Clinical Trial

Last updated: 2/5/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

VTRS

MYLAN

Related Pipeline

Hemophilia B

Pneumococcal Disease

Overactive Bladder

Smoking Cessation

Advanced Breast Cancer Female